|
|||||
|
|
Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag |
|
| Authors: | Beilei Cai Qayyim Said Xin Li Frank Li Steve Arcona |
| Institution: | 1. US Oncology Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;2. Beilei.Cai@novartis.com;4. KMK Consulting Inc, Morristown, NJ, USA |
| Abstract: | |
| Keywords: | Severe aplastic anemia eltrombopag blood transfusion healthcare resource utilization direct costs immunosuppressive therapy |